| 000 | 01266 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516054733.0 | ||
| 264 | 0 | _c20120111 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1875-9114 | ||
| 024 | 7 |
_a10.1592/phco.31.8.725 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHunchuck, Jonathan E | |
| 245 | 0 | 0 |
_aDabigatran for stroke prevention in all patients with atrial fibrillation? _h[electronic resource] |
| 260 |
_bPharmacotherapy _cAug 2011 |
||
| 300 |
_a725-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Editorial | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
| 650 | 0 | 4 |
_aBenzimidazoles _xadverse effects |
| 650 | 0 | 4 | _aDabigatran |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aStroke _xetiology |
| 650 | 0 | 4 |
_aWarfarin _xadverse effects |
| 650 | 0 | 4 |
_abeta-Alanine _xadverse effects |
| 700 | 1 | _aLake, Jennifer D | |
| 773 | 0 |
_tPharmacotherapy _gvol. 31 _gno. 8 _gp. 725-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.31.8.725 _zAvailable from publisher's website |
| 999 |
_c21162547 _d21162547 |
||